Meta-analysis of the association between cigarette smoking and peripheral arterial disease

Heart

Volumn 100, Issue 5, 2014, Pages 414-423

  Lu, L ^a   F Mackay, D ^a   Pell, J P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ANKLE BRACHIAL INDEX; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; COHORT ANALYSIS; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EFFECT SIZE; EGGER TEST; EUROPE; GENETIC HETEROGENEITY; HUMAN; INTERMITTENT CLAUDICATION; MULTIVARIATE ANALYSIS; NORTH AMERICA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING; SOUTH AMERICA; SYSTEMATIC REVIEW; UNIVARIATE ANALYSIS;

PERIPHERAL VASCULAR DISEASE;

HUMANS; INCIDENCE; PERIPHERAL ARTERIAL DISEASE; RISK ASSESSMENT; RISK FACTORS; SMOKING; SURVIVAL RATE; WORLD HEALTH;

EID: 84896690603     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304082     Document Type: Article

References (82)

1. Esson K, Leeder S. The millennium development goals and tobacco control: an opportunity for global partnership. Geneva, Switzerland: World health organization, 2004:11.
2. OrganizationWH.Who report on the global tobacco epidemic, 2011: warning about the dangers of tobacco. Geneva, Switzerland: World health organization, 2011:7.
3. Daar AS, Singer PA, Leah Persad D, et al. Grand challenges in chronic non-communicable diseases. Nature 2007;450:494-6. (Pubitemid 350190238)
4. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011;378:1297-305.
5. Humphries SE, Talmud PJ, Hawe E, et al. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 2001;358:115-19. (Pubitemid 32709850)
6. Huxley RR, Yatsuya H, Lutsey PL, et al. Impact of age at smoking initiation, dosage, and time since quitting on cardiovascular disease in African Americans and Whites. Am J Epidemiol 2012;175:816-26.
7. Negri E, Lavecchia C, Davanzo B, et al. Acute myocardial-infarction- association with time since stopping smoking in Italy. J Epidemiol Community Health 1994;48:129-33. (Pubitemid 24148395)
8. Erb W. Klinische beitrage zur pathologie des intermittierenden hinkens. Munch Med Wochenschr 1911;2:2487.
9. Price JF, Mowbray PI, Lee AJ, et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease. Edinburgh Artery Study. Eur Heart J 1999;20:344-53. (Pubitemid 29103732)
10. Fowkes FGR, Housley E, Riemersma RA, et al. Smoking, lipids, glucose-intolerance, and blood-pressure as risk-factors for peripheral atherosclerosis compared with ischemic-heart-disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331-40.
11. Willigendael EM, Teijink JA, Bartelink ML, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004;40:1158-65. (Pubitemid 40037284)
12. Lassila R, Lepantalo M. Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand 1988;154:635-40. (Pubitemid 19069863)
13. Dormandy J. Management of peripheral arterial disease (PAD). TASC working group. TransatlAntic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:1.
14. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. PLoS Med 2009;6:e1000097.
15. Brevetti G, Oliva G, Silvestro A, et al. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 2004;175:131-8. (Pubitemid 38746919)
16. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Bmj 2003;327:557-60. (Pubitemid 37088507)
17. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Bmj 1997;315:629-34. (Pubitemid 27387172)
18. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54.
19. Higgins JP, Thompson SG, Deeks JJ, et al. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002;7:51-61.
20. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004;23:1663-82. (Pubitemid 38765338)
21. Adler AI, Stevens RJ, Neil A, et al. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002;25:894-9. (Pubitemid 41094289)
22. Escobar C, Blanes I, Ruiz A, et al. Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes. Eur J IntMed 2011;22:275-81.
23. Leng GC, Lee AJ, Fowkes FGR, et al. The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study. Eur Heart J 1995;16:1542-8. (Pubitemid 26037783)
24. Bendermacher BL, Teijink JA, Willigendael EM, et al. A clinical prediction model for the presence of peripheral arterial disease-the benefit of screening individuals before initiation of measurement of the ankle-brachial index: an observational study. Vasc Med 2007;12:5-11. (Pubitemid 46578782)
25. Cacoub P, Cambou JP, Kownator S, et al. Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int J Clin Pract 2009;63:63-70.
26. Faglia E, Caravaggi C, Marchetti R, et al. Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed type 2 diabetic patients. Diabetic Med 2005;22:1310-14. (Pubitemid 41391303)
27. Hooi JD, Stoffers H, Kester ADM, et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease-the Limburg PAOD study. Scand J Prim Health 1998;16:177-82. (Pubitemid 28459675)
28. Jensen SA, Vatten LJ, Nilsen TI, et al. The association between smoking and the prevalence of intermittent claudication. Vasc Med 2005;10:257-63. (Pubitemid 43137275)
29. Kröger K, Dragano N, Stang A, et al. An unequal social distribution of peripheral arterial disease and the possible explanations: results from a population-based study. Vasc Med 2009;14:289-96.
30. Mangion DM, Hawley MS, Norcliffe D. Lower limb arterial disease: assessment of risk factors in an elderly population. Atherosclerosis 1991;91:137-43.
31. Meijer WT, Grobbee DE, Hunink MGM, et al. Determinants of peripheral arterial disease in the elderly: the Rotterdam Study. Arch Intern Med 2000;160:2934-8. (Pubitemid 32009050)
32. Ögren M, Hedblad B, Janzon L. Biased risk factor assessment in prospective studies of peripheral arterial disease due to change in exposure and selective mortality of high-risk individuals. J Cardiovasc risk 1996;3:523-8. (Pubitemid 27142221)
33. Ramos R, Quesada M, Solanas P, et al. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc 2009;38:305-11.
34. Sanna G, Alesso D, Mediati M, et al. Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study data from PANDORA (Prevalence of peripheral arterial disease in subjects with moderate CVD risk, with no overt vascular diseases nor diabetes mellitus). BMC Cardiovasc Disord 2011;11:59.
35. Schgoer W, Eller P, Mueller T, et al. The MTP-493TT genotype is associated with peripheral arterial disease: results from the Linz peripheral arterial disease (LIPAD) study. Clin Biochem 2008;41:712-16.
36. Sigvant B, Wiberg-Hedman K, Bergqvist D, et al. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease. Eur J Cardiovasc Prev Rehabil 2009;16:39-46.
37. Skalkidis Y, Katsouyanni K, Petridou E, et al. Risk factors of peripheral arterial occlusive disease: a case-control study in Greece. Int J Epidemiol 1989;18:614-18. (Pubitemid 19268605)
38. Tapp RJ, Balkau B, Shaw JE, et al. Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study. Atherosclerosis 2007;190:84-9. (Pubitemid 44920232)
39. Törnwall ME, Virtamo J, Haukka JK, et al. Prospective study of diet, lifestyle, and intermittent claudication in male smokers. Am J Epidemiol 2000;151:892-901. (Pubitemid 30461130)
40. Alzamora MT, Fores R, Baena-Diez JM, et al. The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population. BMC Public Health 2010;10:38.
41. Aboyans V, McClelland RL, Allison MA, et al. Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2011;214:169-73.
42. Agarwal S. The association of active and passive smoking with peripheral arterial disease: results from NHANES 1999-2004. Angiology 2009;60:335-45.
43. Allison MA, Criqui MH, McClelland RL, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). JACC 2006;48:19.
44. Collins TC, Suarez-Almazor M, Bush RL, et al. Gender and peripheral arterial disease. J Am Board Fam Med 2006;19:132-40. (Pubitemid 44046975)
45. Gabriel SA, Serafim PH, Freitas CE, et al. Peripheral arterial occlusive disease and ankle-brachial index in patients who had coronary angiography. Rev Bras Cir Cardiovasc 2007;22:49-59.
46. Kennedy M, Solomon C, Manolio TA, et al. Risk factors for declining ankle-brachial index in men and women 1 years or older: the cardiovascular health study. Arch InternMed 2005;165:12
47. McDermott MM, Kerwin DR, Liu K, et al. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med 2001;16:384-90. (Pubitemid 34205656)
48. Murabito JM, Evans JC, Nieto K, et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002;143:961-5. (Pubitemid 34666884)
49. O'Hare AM, Hsu CY, Bacchetti P, et al. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002;13:497-503. (Pubitemid 34106293)
50. Passos VM, Barreto SM, Guerra HL, et al. The Bambui Health and Aging Study (BHAS). Prevalence of intermittent claudication in the aged population of the community of Bambui and its associated factors. Arquivos brasileiros de cardiologia 2001;77:453-62.
51. St-Pierre A, Cantin B, Lamarche B, et al. Intermittent claudication: From its risk factors to its long-term prognosis in men. The Quebec Cardiovascular Study. Can J Cardiol 2010;26:17-21.
52. Taylor-Piliae RE, Fair JM, Varady AN, et al. Ankle brachial index screening in asymptomatic older adults. Am Heart J 2011;161:979-85.
53. Vogt MT, Cauley JA, Kuller LH, et al. Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol 1993;137:559-68. (Pubitemid 23109757)
54. Yeh ST, Morton DJ, Barrett-Connor E. Lower extremity arterial disease in older women: the Rancho Bernardo Study. J Womens Health Gend Based Med 2000;9:373-80. (Pubitemid 30411748)
55. Zheng ZJ, Rosamond WD, Chambless LE, et al. Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and Whites-the Atherosclerosis Risk in Communities (ARIC) study. Am J Prev Med 2005;29:42-9. (Pubitemid 43021816)
56. Bowlin SJ, Mecalie JH, Flocke SA, et al. Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol 1994;140:418-30. (Pubitemid 24281713)
57. Chuengsamarn S, Sangpanich A, Laoopugsin N. Prevalence and risk factors of peripheral arterial disease in type 2 diabetic patients at HRH Princess Maha Chakri Sirindhorn Medical Center. J Med Assoc Thai 2010;93(Suppl 2):S32-38.
58. Cui R, Iso H, Yamagishi K, et al. Relationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese men. Eur J Cardiov Prev R 2006;13:243-8. (Pubitemid 44097730)
59. He Y, Jiang Y, Wang J, et al. Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China. J Vasc Surg 2006;44:333-8. (Pubitemid 44142914)
60. Lee YH, Shin MH, Kweon SS, et al. Cumulative smoking exposure, duration of smoking cessation, and peripheral arterial disease in middle-aged and older Korean men. BMC Public Health 2011;11:94.
61. Li J, Luo Y, Xu Y, et al. Risk factors of peripheral arterial disease and relationship between low ankle brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes. Circulation J 2007;71:377-81. (Pubitemid 46409542)
62. Rhee SY, Guan H, Liu ZM, et al. Multi-country study on the prevalence and clinical features of peripheral arterial disease in Asian type 2 diabetes patients at high risk of atherosclerosis. Diabetes Res Clin Pract 2007;76:82-92. (Pubitemid 46240361)
63. Sritara P, Sritara C, Woodward M, et al. Prevalence and risk factors of peripheral arterial disease in a selected Thai population. Angiology 2007;58:572-8. (Pubitemid 47622829)
64. Tavintharan S, Ning C, Su CL, et al. Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus. Diab Vasc Dis Res 2009;6:80-6.
65. Tseng CH. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with type 2 diabetes. Diabet Med 2004;21:724-9.
66. Woo J, Lynn H, Wong SYS, et al. Correlates for a low ankle-brachial index in elderly Chinese. Atherosclerosis 2006;186:360-6. (Pubitemid 44269073)
67. Yang XM, Sun K, Zhang WL, et al. Prevalence of and risk factors for peripheral arterial disease in the patients with hypertension among Han Chinese. J Vasc Surg 2007;46:296-302. (Pubitemid 47411482)
68. Zheng L, Yu J, Li J, et al. Prevalence of and risk factors for peripheral arterial disease among Chinese hypertensive patients with and without known cardiovascular disease. Acta Cardiol 2008;63:693-9.
69. Maeda Y, Inoguchi T, Tsubouchi H, et al. High prevalence of peripheral arterial disease diagnosed by low ankle-brachial index in Japanese patients with diabetes: the Kyushu Prevention Study for Atherosclerosis. Diabetes Res Clin Pr 2008;82:378-82.
70. Luo YY, Li J, Xin Y, et al. Risk factors of peripheral arterial disease and relationship between low ankle brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with hypertension. J Hum Hypertens 2007;21:461-6. (Pubitemid 46813596)
71. Fowler B, Jamrozik K, Norman P, et al. Prevalence of peripheral arterial disease: persistence of excess risk in former smokers. Aust N Z J Public Health 2002;26:219-24. (Pubitemid 35446369)
72. Lakshmanan R, Hyde Z, Jamrozik K, et al. Population-based observational study of claudication in older men: the health in men study. Med J Australia 2010;192:641-5.
73. Norman PE, Davis WA, Bruce DG, et al. Peripheral arterial disease and risk of cardiac death in type 2 diabetes-the Fremantle Diabetes Study. Diabetes Care 2006;29:575-80. (Pubitemid 44115357)
74. Paul AK, Mash B, Rupesinghe G. Peripheral arterial disease-high prevalence in rural black South Africans. Samj S Afr Med J 2007;97:285-8. (Pubitemid 46614308)
75. Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease-Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006;114:1914-22. (Pubitemid 44665385)
76. Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in stata™. Syst Rev Health Care 2008:347-69.
77. Kollerits B, Heinrich J, Pichler M, et al. Intermittent claudication in the Erfurt Male Cohort (ERFORT) study: its determinants and the impact on mortality-a population-based prospective cohort study with 1 years of follow-up. Atherosclerosis 2008;198:214-22 (Pubitemid 351406363)
78. Conen D, Everett BM, Kurth T, et al. Smoking, smoking cessation, and risk for symptomatic peripheral artery disease in women. Ann Intern Med 2011;154:719-26.
79. Ouriel K. Peripheral arterial disease. Lancet 2001;358:1257-64. (Pubitemid 33010855)
80. He J, Vupputuri S, Allen K, et al. Passive smoking and the risk of coronary heart disease-a meta-analysis of epidemiologic studies. N Engl J Med 1999;340:920-6. (Pubitemid 29141053)
81. He Y, Lam TH, Jiang B, et al. Passive smoking and risk of peripheral arterial disease and ischemic stroke in Chinese women who never smoked. Circulation 2008;118:1535-40.
82. Control RfIT. WHO report on the global tobacco epidemic, 2008: The mpower package. World Health Organization, 2008.\